Press release
CRISPR Therapies Pipeline, FDA Approvals, Clinical Trials Developments and Companies (Updated)
CRISPR Therapies Pipeline
Key Takeaways from the CRISPR Therapies Pipeline Report
• DelveInsight's CRISPR Therapies pipeline report depicts a robust space with 25+ CRISPR Therapies companies working to develop 25+ pipeline therapies for CRISPR Therapies treatment.
• The leading CRISPR Therapies Companies working in the market include Intellia Therapeutics, CRISPR therapeutics, Repare Therapeutics, Beam therapeutics, Caribou Biosciences, Emendo Biotherapeutics, Defence Therapeutics, Sarepta therapeutics, Editas Medicine, Locus Biosciences, Excision BioTherapeutics, AstraZeneca, Novartis, ASC therapeutics, Casebia therapeutics, Spotlight Therapeutics, KSQ Therapeutics, MEDIC Life Sciences, Scribe therapeutics, Arbor Biotechnologies, Sangamo therapeutics, Graphite Bio, Nuntius Therapeutics, and others.
• Promising CRISPR Therapies in the various stages of development include BD111 Adult single group Dose, HG202, CB-011, Cyclophosphamide, Fludarabine, Aldesleukin, EBT-101, and others.
• November 2023: HuidaGene Therapeutics Co. Ltd. announced a study of early phase 1 clinical trials for HG202. A Trial to Evaluate the Safety, Tolerability, and Efficacy of CRISPR-Cas13 RNA-editing Therapy Targeting Knockdown of Vascular Endothelial Growth Factor A (HG202) in the Treatment of Neovascular Age-related Macular Degeneration (nAMD).
• November 2023: Caribou Biosciences Inc. announced a study of Phase 1 clinical trials for CB-011. This is a Phase 1 study to evaluate the safety of CB-011 (the study treatment), an allogeneic chimeric antigen receptor (CAR-T) cell therapy that targets the B cell maturation antigen (BCMA), to determine the best dose of CB-011, and to assess the effectiveness of CB-011 in treating multiple myeloma that has come back (relapsed) or that is no longer responding to other treatment (refractory).
Request a sample and discover the recent advances in CRISPR Therapies Treatment Drugs @ CRISPR Therapies Pipeline Outlook Report- https://www.delveinsight.com/report-store/crispr-therapies-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
The CRISPR Therapies pipeline report provides detailed profiles of pipeline assets, a comparative analysis of clinical and non-clinical stage CRISPR Therapies drugs, inactive and dormant assets, a comprehensive assessment of driving and restraining factors, and an assessment of opportunities and risks in the CRISPR Therapies clinical trial landscape.
CRISPR Therapies Overview
CRISPRs are specialized stretches of DNA. ""CRISPR"" stands for ""clusters of regularly interspaced short palindromic repeats."" It is a specialized region of DNA with two distinct characteristics: the presence of nucleotide repeats and spacers. Repeated sequences of nucleotides - the building blocks of DNA - are distributed throughout a CRISPR region.
Find out more about CRISPR Therapies Treatment Landscape @ Drugs for CRISPR Therapies Treatment- https://www.delveinsight.com/sample-request/crispr-therapies-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
CRISPR Therapies Emerging Drugs Profile
• CTX001: CRISPR Therapeutics
• EDIT-101: Editas Medicine
CRISPR Therapies Pipeline Therapeutics Assessment
There are approx. 25+ key CRISPR Therapies companies which are developing the CRISPR Therapies. The CRISPR Therapies companies which have their CRISPR Therapies drug candidates in the most advanced stage, i.e. Phase I/II include, CRISPR therapeutics.
DelveInsight's CRISPR Therapies Pipeline Report covers around 30+ products under different phases of clinical development like
• Late stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I) along with the details of
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration
CRISPR Therapies pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Oral
• Parenteral
• Intravenous
• Subcutaneous
• Topical.
• Molecule Type
CRISPR Therapies Products have been categorized under various Molecule types such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy
• Product Type
Learn more about the emerging CRISPR Therapies Pipeline Therapies @ CRISPR Therapies Clinical Trials Assessment- https://www.delveinsight.com/sample-request/crispr-therapies-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the CRISPR Therapies Pipeline Report
• Coverage- Global
• CRISPR Therapies Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
• CRISPR Therapies Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
• CRISPR Therapies Companies- Intellia Therapeutics, CRISPR therapeutics, Repare Therapeutics, Beam therapeutics, Caribou Biosciences, Emendo Biotherapeutics, Defence Therapeutics, Sarepta therapeutics, Editas Medicine, Locus Biosciences, Excision BioTherapeutics, AstraZeneca, Novartis, ASC therapeutics, Casebia therapeutics, Spotlight Therapeutics, KSQ Therapeutics, MEDIC Life Sciences, Scribe therapeutics, Arbor Biotechnologies, Sangamo therapeutics, Graphite Bio, Nuntius Therapeutics, and others.
• CRISPR Therapies- BD111 Adult single group Dose, HG202, CB-011, Cyclophosphamide, Fludarabine, Aldesleukin, EBT-101, and others.
Dive deep into rich insights for new drugs for CRISPR Therapies treatment, Visit @ CRISPR Therapies Market Drivers and Barriers, and Future Perspective- https://www.delveinsight.com/sample-request/crispr-therapies-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Introduction
2. Executive Summary
3. CRISPR Therapies: Overview
4. Pipeline Therapeutics
5. Therapeutic Assessment
6. Late Stage Products (Phase III)
7. Drug Name: Company Name
8. Drug profiles in the detailed report…..
9. Early Stage Products (Phase I/II)
10. CTX001: CRISPR Therapeutics
11. Drug profiles in the detailed report…..
12. Early stage products (Phase I)
13. LBP-EC01: Locus Biosciences
14. Drug profiles in the detailed report…..
15. Inactive Products
16. CRISPR Therapies Key Companies
17. CRISPR Therapies Key Products
18. CRISPR Therapies- Unmet Needs
19. CRISPR Therapies- Market Drivers and Barriers
20. CRISPR Therapies- Future Perspectives and Conclusion
21. CRISPR Therapies Analyst Views
22. CRISPR Therapies Key Companies
23. Appendix
For further information on the CRISPR Therapies pipeline therapeutics, reach out to CRISPR Therapies Unmet Needs and Analyst Views- https://www.delveinsight.com/sample-request/crispr-therapies-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
List of Important Published Links
https://quantummemoir.mn.co/members/21285995
https://rightbusinesspath.mn.co/posts/48636294
https://tennispassion.mn.co/posts/48636354
https://king-business.mn.co/posts/48636411
https://forums.mbclub.co.uk/members/dennydones99.180319/#about
https://www.creativelive.com/student/dennydones1?via=accounts-freeform_2
https://tl.net/forum/profile.php?user=dennydones99
https://minne.com/@dennydones99/profile
https://network-79379.mn.co/members/20103624
https://ylimun.mn.co/members/20103614
https://kktix.com/user/5068280
https://network-373.mn.co/posts/48353213
https://body-imagine.mn.co/posts/48353364
https://pimpmyairgun.mn.co/posts/48353478
https://gtribe.mn.co/posts/advancements-and-opportunities-in-the-vulvar-cancer-market
https://communenour.mn.co/posts/emerging-trends-and-market-dynamics-in-vulvar-cancer-treatment
https://synkretic.mn.co/posts/understanding-the-vulvar-cancer-market-trends-challenges-and-innovations
https://jlfa2020.mn.co/members/16644457
https://dbook.mn.co/posts/48401881
https://lxgonline.mn.co/posts/navigating-the-landscape-of-hypertriglyceridemia-market-current-trends-and-future-prospects
https://www.penname.me/@dennydones99
https://community.fyers.in/member/7Yldtdsvui
https://spurstartup.mn.co/posts/48406045
https://pressurecooker.mn.co/posts/48406225
https://regenerative-future.mn.co/posts/navigating-the-hypertriglyceridemia-market-innovations-and-challenges
https://commiss.io/dennydones
https://www.pledgeme.co.nz/profiles/221820/
https://brave-comfort.mn.co/posts/48409148
https://gamebook.mn.co/posts/navigating-the-landscape-of-the-hypertriglyceridemia-market
https://biomolecula.ru/authors/25303
https://discuss.machform.com/u/dennydones9191
https://dagshub.com/dennydones9191
https://careerkarma.com/profile/clr7d7z0c04v2lf3k5lrx9vyr/
https://gotech.mn.co/posts/48477911
https://landmarknew.mn.co/posts/48477947
https://infiniteabundance.mn.co/posts/48478016
https://wellbeingmatters.mn.co/posts/48478424
https://vrjam.mn.co/posts/48478544
https://decidim.santcugat.cat/profiles/dennydones9/activity
https://haveagood.holiday/users/336105
https://participa.rubi.cat/profiles/dennydones9191/activity
https://forum.callofwar.com/index.php?user/60304-dennydones9191/#about
https://connectgalaxy.com/post/146081_syphilis-a-sexually-transmitted-bacterial-infection-caused-by-treponema-pallidum.html
https://www.thebostoncalendar.com/user/74833
https://wrongplanet.net/author/dennydones9999/
https://bookmark.hiauthors.com/story/syphilis-market
https://www.openhumans.org/member/anniethomas/
https://cynochat.com/read-blog/160375
https://hitrecord.org/users/dennydones9999/records
https://biiut.com/read-blog/918
https://nimmansocial.com/story5840956/syphilis-market
https://bookmarkbirth.com/story15878475/syphilis-market
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: ybhardwaj@delveinsight.com
Phone: 9193216187
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/report-store/stem-cell-market
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release CRISPR Therapies Pipeline, FDA Approvals, Clinical Trials Developments and Companies (Updated) here
News-ID: 3350558 • Views: …
More Releases from DelveInsight Business Research LLP
Follicular Lymphoma Clinical Trial Pipeline Appears Robust With 45+ Key Pharma C …
DelveInsight's, "Follicular Lymphoma Pipeline Insight 2025" report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Follicular Lymphoma pipeline landscape. It covers the Follicular Lymphoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Follicular Lymphoma pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Request a sample and discover the…
Muscle Spasticity Clinical Trial Pipeline Appears Robust With 15+ Key Pharma Com …
DelveInsight's "Muscle Spasticity Pipeline Insight 2025" report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in the Muscle Spasticity pipeline landscape. It covers the Muscle Spasticity pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Muscle Spasticity pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Curious about the latest updates…
Brutons Tyrosine Kinase Inhibitors Clinical Trial Pipeline Appears Robust With 3 …
DelveInsight's "Brutons Tyrosine Kinase Inhibitors Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in the Brutons Tyrosine Kinase Inhibitors pipeline landscape. It covers the Brutons Tyrosine Kinase Inhibitors pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Brutons Tyrosine Kinase Inhibitors pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline…
Smoking Cessation Clinical Trial Pipeline Appears Robust With 10+ Key Pharma Com …
DelveInsight's, "Smoking Cessation Pipeline Insight 2025" report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Smoking Cessation pipeline landscape. It covers the Smoking Cessation Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Smoking Cessation Pipeline Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Curious about the latest updates in…
More Releases for CRISPR
CRISPR-based POC Diagnostics Market Set for Strong Expansion | • Illumina • …
➤ Global CRISPR-based POC Diagnostics Market Research Report (2026-2033)
The Worldwide "CRISPR-based POC Diagnostics Market" Research Report 2026 delivers a comprehensive, decision-ready analysis of the global CRISPR-based POC Diagnostics industry, offering clear insights into current market conditions and future growth potential. Developed using a robust research framework, the report combines validated data models, expert analysis, and real-world market intelligence to support strategic decision-making.
This study evaluates the complete market ecosystem, including industry…
Amerigo Scientific Unveils CRISPR/Cas Enzymes to Expand the CRISPR Toolbox
Amerigo Scientific, as a distributor focused on providing critical products and services to biomedical and life science communities, announced the release of a groundbreaking selection of CRISPR/Cas enzymes to its extensive life science portfolio, aimed at further expanding the vast potential of the CRISPR toolbox. This addition brings cutting-edge genetic editing tools to scientists and researchers in a variety of fields.
CRISPR/Cas (Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated) technology revolutionized the…
CRISPR Technology Market - Gene Editing Redefined: Pioneering CRISPR Technology …
Newark, New Castle, USA: The "CRISPR Technology Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
CRISPR Technology Market: https://www.growthplusreports.com/report/crispr-technology-market/7632
This latest report researches the industry structure, sales,…
CRISPR And CRISPR-Associated (Cas) Genes Market Analysis & Trends - Industry For …
LOS ANGELES, United States: The research study presented in this report offers a complete and intelligent analysis of the competition, segmentation, dynamics, and geographical advancement of the global CRISPR And CRISPR-Associated (Cas) Genes market. It takes into account the CAGR, value, volume, revenue, production, consumption, sales, manufacturing cost, prices, and other key factors related to the global CRISPR And CRISPR-Associated (Cas) Genes market. The authors of the report have segmented…
CRISPR & Cas Genes Market Dynamic Growth Factors 2028 | CRISPR Therapeutics, Ast …
"CRISPR & Cas Genes Market" Report offers an in-depth analysis of the market size, share, SWOT Analysis, future progress expansion, industry growth, key development strategies and market trend dynamics which includes drivers, restraints, opportunities prevailing in the industry by product type, application, key manufacturers and key regions and countries.
It also offers advanced statistics as well as some business-driven information associated with the precise industry. It delivers an analytical investigation of the…
CRISPR and CRISPR-Associated (Cas) Genes Market 2022 | Detailed Report
According to Market Study Report, CRISPR and CRISPR-Associated (Cas) Genes Market provides a comprehensive analysis of the CRISPR and CRISPR-Associated (Cas) Genes Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team.
Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4240401
The report provides a comprehensive analysis of company profiles listed below:
-…
